HighTower Advisors »

Seres Therapeutics shares owned by HighTower Advisors

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $22k 16k 1.37
2023-09-30 $50k 21k 2.38
2023-06-30 $101k 21k 4.81
2023-03-31 $83k 15k 5.72
2022-12-31 $73k 13k 5.62
2022-09-30 $83k 13k 6.38